Carryfine SR 200 Tablet
Carryfine SR 200 Tablet provides progesterone, which is a natural hormone essential for reproductive health. It is used to support pregnancy in female infertility and as part of hormone replacement therapy. It helps regulate the menstrual cycle, prepares the uterus for pregnancy, and balances hormones.
Carryfine SR 200 Tablet
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Carryfine SR 200 Tablet provides progesterone, which is a natural hormone essential for reproductive health. It is used to support pregnancy in female infertility and as part of hormone replacement therapy. It helps regulate the menstrual cycle, prepares the uterus for pregnancy, and balances hormones.
Carryfine SR 200 Tablet provides progesterone, which is a natural hormone essential for reproductive health. It is used to support pregnancy in female infertility and as part of hormone replacement therapy. It helps regulate the menstrual cycle, prepares the uterus for pregnancy, and balances hormones.
You should use Carryfine SR 200 Tablet as your doctor has advised. Do not use more or less than you have been advised, and do not use it for longer than recommended. You may be asked to continue taking this medicine for a certain period after it is confirmed that you are pregnant.
The most common side effects include headache, stomach cramps, irregular vaginal bleeding or spotting, fluid retention, and nausea. Your doctor may be able to help you reduce or prevent side effects if they bother you or do not go away. Very occasionally, people get a severe allergic reaction that needs urgent medical attention.
Using this medicine may increase your risk of blood clots or breast cancer. Carryfine SR 200 Tablet may not suit everybody, and you should tell your doctor if you have, or have had, breast cancer, unusual bleeding in the vagina, or liver disease. You may be monitored more carefully if you have liver, kidney, or heart problems or have diabetes or asthma.
Let your doctor know your medical history to make sure it is safe for you. Check with your doctor about all other medicines that may affect, or be affected by, this medicine. You will probably have several tests both before and during treatment to check your womb. This medicine can alter your thinking or reactions, and you may feel very tired, so be careful if you drive or need to be alert.
03Uses
Female infertility
Hormone replacement therapy
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Carryfine SR 200 Tablet is to be taken empty stomach.
05How It Works
Carryfine SR 200 Tablet works by preparing the uterus for pregnancy and maintaining a healthy environment for fetal development. It thickens the uterine lining to support implantation and prevents contractions that could lead to early pregnancy loss. Additionally, it helps regulate the menstrual cycle and balances other reproductive hormones. In hormone therapy, it supports overall hormonal stability and helps manage symptoms related to hormonal imbalances.
06What If You Miss A Dose?
Q: What if you forget to take Carryfine Tablet SR?
A: If you miss a dose of Carryfine SR 200 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Female infertility
Carryfine SR 200 Tablet contains progesterone, a female hormone that is important in the regulation of ovulation and menstruation. It is used to cause menstrual periods in women who have not reached menopause but are not having periods due to a lack of natural progesterone in the body. Progesterone helps to prepare the uterus for pregnancy by causing the uterus lining (endometrium) to thicken. This increases the chance of a successful pregnancy. You should use the medicine as prescribed for it to be effective. You may be asked to continue with this treatment for a period after becoming pregnant.
08Side Effects
Headache
Breast pain
Irregular menstrual cycle
Abdominal cramp
Bloating
Nausea
Vomiting
Hair loss
Vaginal yeast infection
09Safety Information
Alcohol:UNSAFE
Carryfine SR 200 Tablet may cause excessive drowsiness with alcohol.
Pregnancy:CONSULT YOUR DOCTOR
Carryfine SR 200 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Carryfine SR 200 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving:UNSAFE
Carryfine SR 200 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney:CONSULT YOUR DOCTOR
There is limited information available on the use of Carryfine SR 200 Tablet in patients with kidney disease. Please consult your doctor.
Liver:CAUTION
Carryfine SR 200 Tablet should be used with caution in patients with liver disease. Dose adjustment of Carryfine SR 200 Tablet may be needed. Please consult your doctor.
10Drug Tips
Carryfine SR 200 Tablet helps regulate menstrual cycles, treats heavy bleeding, and prevents thickening of the uterus.
Carryfine SR 200 Tablet is also used to restore menstruation in women with secondary amenorrhea (the absence of menstrual cycles).
Carryfine SR 200 Tablet is best taken without food, preferably in the evening or at bedtime.
It may cause sleepiness or drowsiness. Do not drive or do anything that requires mental focus until you know how Carryfine SR 200 Tablet affects you.
It may cause bleeding or spotting between menstrual periods. Let your doctor know if this occurs frequently.
References
Sources and references
Chrousos GP. The Gonadal Hormones & Inhibitors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 706-707.
Levin ER, Hammes SR. Estrogens and Progestins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1180-85.
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 03 Apr. 2019] (online) Available from: View
Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from: View
Progesterone [Prescribing Information]. St. Petersburg, FL: Catalent Pharma Solutions; 2009. [Accessed 28 Mar. 2023] (online) Available from: View
Progesterone [Prescribing Information]. Hyderabad, India: Eugia Pharma Specialities Limited; 2024. [Accessed 04 Mar. 2024] (online) Available from: View
